Market Overview:
The global colestipol market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of hyperlipidemia and rising awareness about the benefits of colestipol therapy. Colestipol is a bile acid sequestrant that is used for the treatment of hyperlipidemia, including high cholesterol and triglyceride levels. It reduces serum cholesterol levels by binding with bile acids in the intestine, which prevents their reabsorption into the bloodstream. This leads to an increase in hepatic synthesis of cholesterol, which lowers serum cholesterol levels. Colestipol is available as granules and tablets in different dosages, depending on patient needs. It is generally prescribed in combination with other lipid-lowering drugs such as statins or fibrates for better results. The global colestipol market has been segmented on the basis of type (granules and tablets), application (hospital pharmacies and drug stores), and region (North America, Latin America, Europe Asia Pacific & Middle East & Africa).
Product Definition:
Colestipol is a drug used to lower cholesterol levels.
Granule:
Granule is a free-flowing powder made from calcium carbonate. It has high demand in the pharmaceutical industry as an excipient for various drug products such as tablets, capsules and other oral solid dosage forms. Granules are used to produce Colestipol which is a lipase inhibitor that reduces cholesterol absorption in the small intestine and thus reduces the production of low-density lipoprotein (LDL) by liver cells.
Tablet:
A tablet is a pharmaceutical dosage form that contains an amount of drug required to be mixed with a liquid carrier for oral administration. The most commonly used tablets are those containing analgesic, anti-inflammatory drugs, and paracetamol. Tablets are available as both generic as well as branded formulations which makes them easily available across the market place and also helps in easy differentiation between the two products offered by different companies.
Application Insights:
The drug store application segment accounted for the largest share of over 70.0% in 2017. The product is widely used as an anti-gas, anti-emetic and antidiarrheal agent owing to its properties that prevent gas formation and promote gastric motility. It is also employed in drugs to prevent nausea caused by other substances when they are taken with colestipol, such as vitamin B6 deficiency or during chemotherapy treatment with alkylating agents.
Hospital applications are anticipated to witness a lucrative CAGR of XX% from 2018 to 2030 on account of increasing utilization in pharmaceutical preparations for diarrhea treatment due to its high stool softening property without the risk of constipation or hard stools like lumps do not form after taking it along with meals every day Colestipol acts as a good source for calcium carbonate which helps maintain intestinal regularity.
Regional Analysis:
North America colestipol market is anticipated to witness growth over the forecast period owing to increasing cases of IBD. The region accounted for a share of more than 30% in 2017 and is expected to grow at a lucrative rate over the forecast period. However, Asia Pacific and Latin America are projected to be the most promising regions during the same period owing to growing healthcare expenditure, rising awareness about colitis disease treatment options, improving economic conditions & rapid urbanization & industrialization in these regions.
The global market has been segmented into North America, Europe, Asia Pacific (APAC), Central & South America (CSA) and Middle East Africa (MEA).
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Growing geriatric population
- Rising awareness about the benefits of colestipol therapy
- Availability of generic versions of the drug
- Launch of novel colestipol formulations
Scope Of The Report
Report Attributes
Report Details
Report Title
Colestipol Market Research Report
By Type
Granule, Tablet
By Application
Hospital, Drug Store
By Companies
Pfizer, Amneal Pharmaceuticals, Solara Active Pharma Sciences, Cadila Healthcare, Mylan, Formosa Laboratories, Vijayasri Organics Limited, Apothecon Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Colestipol Market Report Segments:
The global Colestipol market is segmented on the basis of:
Types
Granule, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Amneal Pharmaceuticals
- Solara Active Pharma Sciences
- Cadila Healthcare
- Mylan
- Formosa Laboratories
- Vijayasri Organics Limited
- Apothecon Pharmaceuticals
Highlights of The Colestipol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Granule
- Tablet
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Colestipol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Colestipol is a medication used to treat high blood pressure. It works by reducing the amount of fluid in the body.
Some of the major companies in the colestipol market are Pfizer, Amneal Pharmaceuticals, Solara Active Pharma Sciences, Cadila Healthcare, Mylan, Formosa Laboratories, Vijayasri Organics Limited, Apothecon Pharmaceuticals.
The colestipol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Colestipol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Colestipol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Colestipol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Colestipol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Colestipol Market Size & Forecast, 2018-2028
4.5.1 Colestipol Market Size and Y-o-Y Growth
4.5.2 Colestipol Market Absolute $ Opportunity
Chapter 5 Global Colestipol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Colestipol Market Size Forecast by Type
5.2.1 Granule
5.2.2 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Colestipol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Colestipol Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Colestipol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Colestipol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Colestipol Analysis and Forecast
9.1 Introduction
9.2 North America Colestipol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Colestipol Market Size Forecast by Type
9.6.1 Granule
9.6.2 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Colestipol Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Colestipol Analysis and Forecast
10.1 Introduction
10.2 Europe Colestipol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Colestipol Market Size Forecast by Type
10.6.1 Granule
10.6.2 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Colestipol Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Colestipol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Colestipol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Colestipol Market Size Forecast by Type
11.6.1 Granule
11.6.2 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Colestipol Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Colestipol Analysis and Forecast
12.1 Introduction
12.2 Latin America Colestipol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Colestipol Market Size Forecast by Type
12.6.1 Granule
12.6.2 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Colestipol Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Colestipol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Colestipol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Colestipol Market Size Forecast by Type
13.6.1 Granule
13.6.2 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Colestipol Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Colestipol Market: Competitive Dashboard
14.2 Global Colestipol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Amneal Pharmaceuticals
14.3.3 Solara Active Pharma Sciences
14.3.4 Cadila Healthcare
14.3.5 Mylan
14.3.6 Formosa Laboratories
14.3.7 Vijayasri Organics Limited
14.3.8 Apothecon Pharmaceuticals
